| 期刊全称 | Transboundary and Emerging Diseases | |||||||||||||||||||||||||||||||||||||||
| 期刊缩写 | Transboundary Emerging Dis. | |||||||||||||||||||||||||||||||||||||||
|
涉及主题
（科研通AI识别） |
||||||||||||||||||||||||||||||||||||||||
| 期刊介绍 | Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions): Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread. Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope. Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies. Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies). Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope. | |||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | print: 1865-1674on-line: 1865-1682 | |||||||||||||||||||||||||||||||||||||||
| 2026最新影响因子 (2026年6月17日发布) 与上一年的差值 |
2.6↓ 0.4 | |||||||||||||||||||||||||||||||||||||||
| 历年影响因子 |
|
|||||||||||||||||||||||||||||||||||||||
| 历年发表/被引量 （科研通AI通过大数据分析） 最后更新日期：2026-08-10 |
|
|||||||||||||||||||||||||||||||||||||||
| h-index（2021） | 52 | |||||||||||||||||||||||||||||||||||||||
| 自引率 | 2.90% | |||||||||||||||||||||||||||||||||||||||
| 涉及的研究领域 | 农林科学-传染病学 | |||||||||||||||||||||||||||||||||||||||
| 2026年新锐分区 （2026年3月24日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 2026年WOS期刊分区 （2026年6月17日发布） |
JCR学科分类
JCI学科分类
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2025年分区 （2025年3月20日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2024年分区 （2023年12月27日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院《国际期刊预警名单（试行）》名单 |
2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 |
|||||||||||||||||||||||||||||||||||||||
| 期刊主页 |
（系统检测到多个链接，仅供参考，如有错误，请通过页面底部反馈） |
|||||||||||||||||||||||||||||||||||||||
| 投稿网址 | http://mc.manuscriptcentral.com/tbed | |||||||||||||||||||||||||||||||||||||||
| 编辑部地址 | WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148 | |||||||||||||||||||||||||||||||||||||||
| 出版商 | Wiley-Blackwell Publishing Ltd | |||||||||||||||||||||||||||||||||||||||
| 出版国家（地区） | GERMANY | |||||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||||||||||
| 创刊年份 | 2008 | |||||||||||||||||||||||||||||||||||||||
| 每年出版文章数 | 439 | |||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||||||||||||||||||||
| 原创研究文献占比 （排除综述） |
93.71% | |||||||||||||||||||||||||||||||||||||||
| SCI收录类型 |
Science Citation Index Expanded (SCIE) Scopus (CiteScore) |
|||||||||||||||||||||||||||||||||||||||
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1865-1674%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||
| 平均审稿周期 | 网友分享经验： 较慢,18-36周 |
|||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 |
|||||||||||||||||||||||||||||||||||||||
| 相关链接 |
您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。
|
|||||||||||||||||||||||||||||||||||||||
皖公网安备34019202002308
